Urinalysis is a medical test that includes a physical examination of the urine, chemical evaluation, and microscopic examination. The urinalysis test check the appearance, concentration, and content of urine. It is often done to check for a kidney problems (such as chronic kidney diseases), urinary tract infections (UTIs), or diabetes. Thus, with the increasing prevalence of chronic kidney disease, urinary tract infections, and diabetes, the use of urinalysis is also increasing rapidly, worldwide.

Market Dynamics:

Growing prevalence of chronic kidney disease, rise in burden of diabetes, growing geriatric (aging) population, increasing demand for urinalysis products/services, and increasing awareness among people about urinalysis is expected to drive growth of the global urinalysis market.

For instance, in September 2022, Sysmex Corporation announced the launch of the new UF-1500 fully automatic urine particle analysing tool for urine sediment testing to strengthen & expand its product portfolio while maintaining its market position. Moreover, in July 2022, Arkray launched AUTION AI-4510, an innovative automated urine sediment analyzer with built-in capabilities to speed up operations and with auto dilution that eliminates waste and ensures greater accuracy.  

However, stringent regulatory framework and high cost of research and development is expected to hamper the growth of the global urinalysis market.

Key features of the study:

• This report provides in-depth analysis of the global urinalysis market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global urinalysis market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Arkray Inc., Abbott Laboratories, Eiken Chemical Co. Ltd., Sysmex Corporation, Siemens Healthineers AG, Cardinal Health Inc., Acon Laboratories Inc., Bio-Rad Laboratories Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., and Danaher Corporation (Beckman Coulter Inc.).
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global urinalysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global urinalysis market.

Detailed Segmentation:

• Global Urinalysis Market, By Product Type:
  • Instruments
  • Consumables
• Global Urinalysis Market, By Test Type:
  • Biochemical
  • Pregnancy and Fertility
  • Sediment
• Global Urinalysis Market, By Application:
  • Disease Screening
  • Pregnancy and Fertility
• Global Urinalysis Market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • Arkray Inc.
  • Abbott Laboratories
  • Eiken Chemical Co. Ltd.
  • Sysmex Corporation
  • Siemens Healthineers AG
  • Cardinal Health Inc.
  • Acon Laboratories Inc.
  • Bio-Rad Laboratories Inc.
  • Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Danaher Corporation (Beckman Coulter Inc.)